A detailed history of Franklin Resources Inc transactions in Arcellx, Inc. stock. As of the latest transaction made, Franklin Resources Inc holds 56,753 shares of ACLX stock, worth $5.13 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
56,753
Previous 56,701 0.09%
Holding current value
$5.13 Million
Previous $3.13 Million 51.45%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$50.91 - $86.61 $2,647 - $4,503
52 Added 0.09%
56,753 $4.74 Million
Q2 2024

Aug 14, 2024

BUY
$49.74 - $66.98 $117,535 - $158,273
2,363 Added 4.35%
56,701 $3.13 Million
Q1 2024

May 13, 2024

BUY
$51.85 - $73.49 $1.87 Million - $2.65 Million
36,095 Added 197.86%
54,338 $3.78 Million
Q3 2023

Nov 13, 2023

BUY
$31.51 - $37.4 $193,565 - $229,748
6,143 Added 50.77%
18,243 $654,000
Q2 2023

Aug 11, 2023

BUY
$27.49 - $46.9 $332,629 - $567,490
12,100 New
12,100 $382,000

Others Institutions Holding ACLX

About Arcellx, Inc.


  • Ticker ACLX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,819,200
  • Market Cap $3.96B
  • Description
  • Arcellx, Inc., a clinical-stage biotechnology company, engages in the development of various immunotherapies for patients with cancer and other incurable diseases. The company's lead ddCAR product candidate is CART-ddBCMA, which is in phase 1 clinical trial for the treatment of patients with relapsed or refractory (r/r) multiple myeloma (MM). It...
More about ACLX
Track This Portfolio

Track Franklin Resources Inc Portfolio

Follow Franklin Resources Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

News

Stay updated on Franklin Resources Inc with notifications on news.